Results 81 to 90 of about 42,463 (228)
Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin–yang situation? [PDF]
, 2010 Secondary hyperparathyroidism in chronic kidney disease (CKD) develops in response to disturbances in calcium and phosphate metabolism associated with CKD, including FGF23 and klotho.
Tilman B. Drüeke +16 more
core +1 more source
Quantification of SARM1 NADase Activity in Human Peripheral Blood Mononuclear Cells
The FASEB Journal, Volume 40, Issue 9, 15 May 2026.Proposed model for NAD+ metabolism in (A) control and (B) SARM1 activated PBMCs. In native form, 3‐AP and Vacor compete with NAM as an alternative substrate for NAMPT. This consequently decreases generation of NMN and biosynthesis of NAD+ is limited by both a reduction in precursor NMN and direct inhibition of NMNAT by Vacor‐MN and 3‐AP‐MN.
Lila F. Dabill +5 more
wiley +1 more source
Metastatic pulmonary calcification [PDF]
, 2016 Metastatic pulmonary calcification (MPC) may develop in patients with secondary hyperparathyroidism, related to end-stage renal disease (ESRD).1 The histologic pulmonary findings show calcium deposition in the lung interstitium, alveolar septa and ...
Baskin, Mark Harold +2 more
core
A Systematic Review on the Implication of Minerals in the Onset, Severity and Treatment of Periodontal Disease [PDF]
, 2016 Periodontal disease is an inflammatory disease with high prevalence in adults that leads to destruction of the teeth-supporting tissues. Periodontal therapy has been traditionally directed at reduction of the bacterial load to a level that encourages ...
Battino, Maurizio +4 more
core +5 more sources
When an Oral Lesion Uncovers Hyperparathyroidism: A Peripheral Brown Tumor Case
Clinical Case Reports, Volume 14, Issue 5, May 2026.ABSTRACT Oral lesions may represent the first sign of an underlying systemic disease. Giant cell lesions in the oral cavity should prompt investigation for hyperparathyroidism, as early recognition of brown tumors allows appropriate systemic management and may lead to lesion regression after treatment of the endocrine disorder.
Bruno Teixeira Gonçalves Rodrigues +6 more
wiley +1 more source
Eurasian Journal of Medicine, 2019 Parathyroid hormone (PTH) has been shown to enhance erythrocyte osmotic fragility and has been incriminated as a factor in the anemia seen in patients with chronic renal failure and secondary hyperparathyroidism.
Celalettin Koşan, Lale Sever
doaj
Clinical Case Reports, Volume 14, Issue 5, May 2026.ABSTRACT Severe hypertriglyceridemia (HTG) can interfere with laboratory assays. HTG‐induced pancreatitis usually presents with hypocalcemia, but the effect of severe HTG, with no associated pancreatitis, on calcium levels is not well described. We present a 25‐year‐old male with severe HTG and diabetes who presented with generalized weakness, nausea ...
Mohamed Abuelazm +7 more
wiley +1 more source
International Journal of Endocrinology, 2009 Brown tumour represents a serious complication of hyperparathyroidism. Differential diagnosis, based on histological examination, is only presumptive and clinical, radiological and laboratory data are necessary for definitive diagnosis. Here we describe
Nicola Di Daniele +6 more
doaj +1 more source
DIAGNOSTICS AND TREATMENT OF PRIMARY AND SECONDARY HYPERPARATHYROIDISM
Вестник хирургии имени И.И. Грекова, 2018 The experience of treatment of 41 patients (aged 32–67years) was presented in the article. The duration of disease was 2–5 years. Primary hyperparathyroidism was diagnosed in 16 patients and secondary — in 25. Diagnostics of the disease included clinical
M. F. Zarivchatskiy +4 more
doaj +1 more source
Objective assessment of functional and motor-cognitive outcomes among asymptomatic primary hyperparathyroidism patients undergoing parathyroidectomy using wearable technologies: a pilot study towards better informed clinical decision-making [PDF]
, 2017 For the past 40 years, most patients with Primary Hyperparathyroidism (PHPT) have presented with the asymptomatic form of PHPT. Despite the dominance of the asymptomatic PHPT phenotype, current National Institutes of Health (NIH) indications for ...
Siddiqi, Noreen
core